Dena Howard
0000-0003-3333-9783
University of Leeds
3 papers found
Refreshing results…
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling
Missing publications? Search for publications with a matching author name.